Two new reports show medicine price growth continues to decline January 18, 2019 ______________________________________________________________________________________________ Last year, the U.S. Food and Drug Administration approved a record 59 new treatments and cures. During this incredible period of innovation, medicine price growth continued to slow dramatically. Related Posts ICYMI: WSJ and NYT highlight concerns with Part B International Pricing Index Model Here’s how America’s biopharmaceutical companies lead the way in development of innovative new medicines Taisho Pharma to buy Bristol-Myers Squibb’s consumer health business in deal worth $1.6 bn About The Author admin
Here’s how America’s biopharmaceutical companies lead the way in development of innovative new medicines